Matches in SemOpenAlex for { <https://semopenalex.org/work/W2955260342> ?p ?o ?g. }
- W2955260342 abstract "Abstract Immune checkpoint inhibitors are among the newest, cutting‐edge methods for the treatment of cancer. Currently, they primarily influence T cell adaptive immunotherapy targeting the PD‐1/PD‐L1 and CTLA‐4/B7 signalling pathways. These inhibitors fight cancer by reactivating the patient's own adaptive immune system, with good results in many cancers. With the discovery of the “Don't Eat Me” molecule, CD47, antibody‐based drugs that target the macrophage‐related innate immunosuppressive signalling pathway, CD47‐SIRPα, have been developed and have achieved stunning results in the laboratory and the clinic, but there remain unexplained instances of tumour immune escape. While investigating the immunological tolerance of cancer to anti‐CD47 antibodies, a second “Don't Eat Me” molecule on tumour cells, beta 2 microglobulin (β2m), a component of MHC class I, was described. Some tumour cells reduce their surface expression of MHC class I to escape T cell recognition. However, other tumour cells highly express β2m complexed with the MHC class I heavy chain to send a “Don't Eat Me” signal by binding to leucocyte immunoglobulin‐like receptor family B, member 1 (LILRB1) on macrophages, leading to a loss of immune surveillance. Investigating the mechanisms underlying this immunosuppressive MHC class I‐LILRB1 signalling axis in tumour‐associated macrophages will be useful in developing therapies to restore macrophage function and control MHC class I signalling in patient tumours. The goal is to promote adaptive immunity while suppressing the innate immune response to tumours. This work will identify new therapeutic targets for the development of pharmaceutical‐based tumour immunotherapy." @default.
- W2955260342 created "2019-07-12" @default.
- W2955260342 creator A5004684051 @default.
- W2955260342 creator A5023491705 @default.
- W2955260342 creator A5069475690 @default.
- W2955260342 creator A5077182369 @default.
- W2955260342 creator A5084465307 @default.
- W2955260342 creator A5088116645 @default.
- W2955260342 date "2019-07-23" @default.
- W2955260342 modified "2023-10-18" @default.
- W2955260342 title "The MHC class I‐LILRB1 signalling axis as a promising target in cancer therapy" @default.
- W2955260342 cites W1482164699 @default.
- W2955260342 cites W1518342882 @default.
- W2955260342 cites W1551029743 @default.
- W2955260342 cites W1570288335 @default.
- W2955260342 cites W1912449747 @default.
- W2955260342 cites W1968736434 @default.
- W2955260342 cites W1970045790 @default.
- W2955260342 cites W1973968158 @default.
- W2955260342 cites W1974777107 @default.
- W2955260342 cites W1981579151 @default.
- W2955260342 cites W1985936000 @default.
- W2955260342 cites W1996145004 @default.
- W2955260342 cites W1996668456 @default.
- W2955260342 cites W2008416870 @default.
- W2955260342 cites W2009248246 @default.
- W2955260342 cites W2012551275 @default.
- W2955260342 cites W2018192985 @default.
- W2955260342 cites W2020519329 @default.
- W2955260342 cites W2021525821 @default.
- W2955260342 cites W2023495487 @default.
- W2955260342 cites W2030307609 @default.
- W2955260342 cites W2033607892 @default.
- W2955260342 cites W2035494444 @default.
- W2955260342 cites W2037036587 @default.
- W2955260342 cites W2040761710 @default.
- W2955260342 cites W2063533150 @default.
- W2955260342 cites W2069197942 @default.
- W2955260342 cites W2073673847 @default.
- W2955260342 cites W2074677800 @default.
- W2955260342 cites W2080776128 @default.
- W2955260342 cites W2085112759 @default.
- W2955260342 cites W2094600991 @default.
- W2955260342 cites W2097126393 @default.
- W2955260342 cites W2099920681 @default.
- W2955260342 cites W2100016046 @default.
- W2955260342 cites W2102213792 @default.
- W2955260342 cites W2103746815 @default.
- W2955260342 cites W2110942856 @default.
- W2955260342 cites W2113047034 @default.
- W2955260342 cites W2119670049 @default.
- W2955260342 cites W2122221360 @default.
- W2955260342 cites W2124988830 @default.
- W2955260342 cites W2139898172 @default.
- W2955260342 cites W2140938071 @default.
- W2955260342 cites W2141436376 @default.
- W2955260342 cites W2147391835 @default.
- W2955260342 cites W2148212325 @default.
- W2955260342 cites W2152529416 @default.
- W2955260342 cites W2160834915 @default.
- W2955260342 cites W2161442070 @default.
- W2955260342 cites W2161934710 @default.
- W2955260342 cites W2163371670 @default.
- W2955260342 cites W2166126168 @default.
- W2955260342 cites W2169402613 @default.
- W2955260342 cites W2195967565 @default.
- W2955260342 cites W2267250079 @default.
- W2955260342 cites W2313124928 @default.
- W2955260342 cites W2315471038 @default.
- W2955260342 cites W2344439421 @default.
- W2955260342 cites W2345161596 @default.
- W2955260342 cites W2410004221 @default.
- W2955260342 cites W2578528809 @default.
- W2955260342 cites W2592666036 @default.
- W2955260342 cites W2594014934 @default.
- W2955260342 cites W2594264217 @default.
- W2955260342 cites W2597064996 @default.
- W2955260342 cites W2604616997 @default.
- W2955260342 cites W2605934824 @default.
- W2955260342 cites W2615301036 @default.
- W2955260342 cites W2626512221 @default.
- W2955260342 cites W2626763528 @default.
- W2955260342 cites W2677663897 @default.
- W2955260342 cites W2734148025 @default.
- W2955260342 cites W2736476343 @default.
- W2955260342 cites W2744546677 @default.
- W2955260342 cites W2766209631 @default.
- W2955260342 cites W2766881846 @default.
- W2955260342 cites W2768892314 @default.
- W2955260342 cites W2770628073 @default.
- W2955260342 cites W2771371025 @default.
- W2955260342 cites W2778954208 @default.
- W2955260342 cites W2783792325 @default.
- W2955260342 cites W2783899879 @default.
- W2955260342 cites W2797008586 @default.
- W2955260342 cites W2806546829 @default.
- W2955260342 cites W2901754540 @default.
- W2955260342 cites W608522650 @default.
- W2955260342 doi "https://doi.org/10.1111/sji.12804" @default.
- W2955260342 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31267559" @default.